265 2023 lazio English-speaking jobs in Lombardy

In 2023, Grünenthal employed around 4,400 people and achieved revenues of € 1.8bn. #J-18808-Ljbffr

In 2023, we employed around 4,400 people and generated revenues of €1.8 billion. #J-18808-Ljbffr

In 2023, Grünenthal employed around 4,400 people and achieved revenues of € 1.8bn.

*Consolidated Financial Results at June 30, 2023 Operational Audit and Methodologies Analyst The Resource

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

years of experience, approximately 30,000 employees, 108 plants, and 26 R&D centers worldwide, our 2023

years of experience, approximately 30,000 employees, 108 plants, and 26 R&D centers worldwide, our 2023

years of experience, approximately 30,000 employees, 108 plants, and 26 R&D centers worldwide, our 2023

Since 2023, Fondazione Telethon is also the holder of marketing authorization in Europe for Strimvelis

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

In 2023, we reported revenues of approximately €33.6 billion.

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

With over 55 years of heritage, 340,000 team members across more than 50 countries, and 2023 revenues

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023

and as the World's Best Independent Hotel PMS Provider 2022 and 2023 by the World Travel Tech Awards ... achievements don't stop there; Mews was also listed among the World's Best Hotel PMS Provider 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023